COVID-19 Impact on Global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs, Market Insights and Forecast to 2026
- BMR3903726
- 111 Pages
- June 2020
- Healthcare
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs industry.
Based on our recent survey, we have several different scenarios about the ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Sales and Pricing Analyses
Readers are provided with deeper sales analysis and pricing analysis for the global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs market.
The following manufacturers are covered in this report:
GlaxoSmithKline
Helsinn
Heron Therapeutics
Merck
Tesaro
...
ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Breakdown Data by Type
5-HT3 Inhibitors
NK1 Inhibitors
Other
ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Breakdown Data by Application
Highly Emetogenic Chemotherapy
Moderately Emetogenic Chemotherapy
Low Emetogenic Chemotherapy
Other
1.1 ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Product Introduction
1.2 Market Segments
1.3 Key ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Market Size Growth Rate by Type
1.4.2 5-HT3 Inhibitors
1.4.3 NK1 Inhibitors
1.4.4 Other
1.5 Market by Application
1.5.1 Global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Market Size Growth Rate by Application
1.5.2 Highly Emetogenic Chemotherapy
1.5.3 Moderately Emetogenic Chemotherapy
1.5.4 Low Emetogenic Chemotherapy
1.5.5 Other
1.6 Coronavirus Disease 2019 (Covid-19): ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Industry Impact
1.6.1 How the Covid-19 is Affecting the ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Industry
1.6.1.1 ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Market Size Estimates and Forecasts
2.1.1 Global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue 2015-2026
2.1.2 Global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales 2015-2026
2.2 ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Market Size by Region: 2020 Versus 2026
2.2.1 Global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Competitor Landscape by Players
3.1 ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Manufacturers
3.1.1 ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Manufacturers (2015-2020)
3.1.2 ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue by Manufacturers
3.2.1 ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue by Manufacturers (2015-2020)
3.2.2 ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue in 2019
3.2.5 Global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Price by Manufacturers
3.4 ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Manufacturing Base Distribution, Product Types
3.4.1 ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Product Type
3.4.3 Date of International Manufacturers Enter into ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Market Size by Type (2015-2020)
4.1.1 Global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Type (2015-2020)
4.1.2 Global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue by Type (2015-2020)
4.1.3 ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Forecast by Type (2021-2026)
4.2.3 ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
5.1 Global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Market Size by Application (2015-2020)
5.1.1 Global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Application (2015-2020)
5.1.2 Global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue by Application (2015-2020)
5.1.3 ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Price by Application (2015-2020)
5.2 ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs by Country
6.1.1 North America ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Country
6.1.2 North America ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Market Facts & Figures by Type
6.3 North America ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs by Country
7.1.1 Europe ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Country
7.1.2 Europe ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Market Facts & Figures by Type
7.3 Europe ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs by Region
8.1.1 Asia Pacific ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Region
8.1.2 Asia Pacific ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Market Facts & Figures by Type
8.3 Asia Pacific ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs by Country
9.1.1 Latin America ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Country
9.1.2 Latin America ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Market Facts & Figures by Type
9.3 Central & South America ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs by Country
10.1.1 Middle East and Africa ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Country
10.1.2 Middle East and Africa ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Market Facts & Figures by Type
10.3 Middle East and Africa ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Corporation Information
11.1.2 GlaxoSmithKline Description, Business Overview and Total Revenue
11.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GlaxoSmithKline ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Products Offered
11.1.5 GlaxoSmithKline Recent Development
11.2 Helsinn
11.2.1 Helsinn Corporation Information
11.2.2 Helsinn Description, Business Overview and Total Revenue
11.2.3 Helsinn Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Helsinn ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Products Offered
11.2.5 Helsinn Recent Development
11.3 Heron Therapeutics
11.3.1 Heron Therapeutics Corporation Information
11.3.2 Heron Therapeutics Description, Business Overview and Total Revenue
11.3.3 Heron Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Heron Therapeutics ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Products Offered
11.3.5 Heron Therapeutics Recent Development
11.4 Merck
11.4.1 Merck Corporation Information
11.4.2 Merck Description, Business Overview and Total Revenue
11.4.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Merck ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Products Offered
11.4.5 Merck Recent Development
11.5 Tesaro
11.5.1 Tesaro Corporation Information
11.5.2 Tesaro Description, Business Overview and Total Revenue
11.5.3 Tesaro Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Tesaro ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Products Offered
11.5.5 Tesaro Recent Development
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Corporation Information
11.1.2 GlaxoSmithKline Description, Business Overview and Total Revenue
11.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GlaxoSmithKline ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Products Offered
11.1.5 GlaxoSmithKline Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Market Estimates and Projections by Region
12.1.1 Global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Forecast by Regions 2021-2026
12.2 North America ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Market Size Forecast (2021-2026)
12.2.1 North America: ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Forecast (2021-2026)
12.2.2 North America: ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Forecast (2021-2026)
12.2.3 North America: ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Forecast (2021-2026)
12.3.2 Europe: ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
Table 1. ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Market Segments
Table 2. Ranking of Global Top ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of 5-HT3 Inhibitors
Table 5. Major Manufacturers of NK1 Inhibitors
Table 6. Major Manufacturers of Other
Table 7. COVID-19 Impact Global Market: (Four ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Players to Combat Covid-19 Impact
Table 12. Global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 13. Global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 14. Global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Regions 2015-2020 (K Pcs)
Table 15. Global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Regions (2015-2020)
Table 16. Global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 17. Global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Manufacturers (2015-2020) (K Pcs)
Table 18. Global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Share by Manufacturers (2015-2020)
Table 19. Global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 20. Global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs as of 2019)
Table 21. ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 22. ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Share by Manufacturers (2015-2020)
Table 23. Key Manufacturers ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Price (2015-2020) (USD/Pcs)
Table 24. ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Product Type
Table 26. Date of International Manufacturers Enter into ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Type (2015-2020) (K Pcs)
Table 29. Global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Share by Type (2015-2020)
Table 30. Global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue by Type (2015-2020) (US$ Million)
Table 31. Global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Share by Type (2015-2020)
Table 32. ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 33. Global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Application (2015-2020) (K Pcs)
Table 34. Global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Share by Application (2015-2020)
Table 35. North America ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Country (2015-2020) (K Pcs)
Table 36. North America ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Country (2015-2020)
Table 37. North America ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue by Country (2015-2020) (US$ Million)
Table 38. North America ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Market Share by Country (2015-2020)
Table 39. North America ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Type (2015-2020) (K Pcs)
Table 40. North America ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Type (2015-2020)
Table 41. North America ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Application (2015-2020) (K Pcs)
Table 42. North America ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Application (2015-2020)
Table 43. Europe ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Country (2015-2020) (K Pcs)
Table 44. Europe ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Country (2015-2020)
Table 45. Europe ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue by Country (2015-2020) (US$ Million)
Table 46. Europe ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Market Share by Country (2015-2020)
Table 47. Europe ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Type (2015-2020) (K Pcs)
Table 48. Europe ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Type (2015-2020)
Table 49. Europe ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Application (2015-2020) (K Pcs)
Table 50. Europe ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Application (2015-2020)
Table 51. Asia Pacific ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Region (2015-2020) (K Pcs)
Table 52. Asia Pacific ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Region (2015-2020)
Table 53. Asia Pacific ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue by Region (2015-2020) (US$ Million)
Table 54. Asia Pacific ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Market Share by Region (2015-2020)
Table 55. Asia Pacific ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Type (2015-2020) (K Pcs)
Table 56. Asia Pacific ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Type (2015-2020)
Table 57. Asia Pacific ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Application (2015-2020) (K Pcs)
Table 58. Asia Pacific ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Application (2015-2020)
Table 59. Latin America ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Country (2015-2020) (K Pcs)
Table 60. Latin America ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Country (2015-2020)
Table 61. Latin Americaa ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue by Country (2015-2020) (US$ Million)
Table 62. Latin America ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Market Share by Country (2015-2020)
Table 63. Latin America ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Type (2015-2020) (K Pcs)
Table 64. Latin America ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Type (2015-2020)
Table 65. Latin America ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Application (2015-2020) (K Pcs)
Table 66. Latin America ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Application (2015-2020)
Table 67. Middle East and Africa ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Country (2015-2020) (K Pcs)
Table 68. Middle East and Africa ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Country (2015-2020)
Table 69. Middle East and Africa ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue by Country (2015-2020) (US$ Million)
Table 70. Middle East and Africa ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Type (2015-2020) (K Pcs)
Table 72. Middle East and Africa ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Type (2015-2020)
Table 73. Middle East and Africa ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Application (2015-2020) (K Pcs)
Table 74. Middle East and Africa ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Application (2015-2020)
Table 75. GlaxoSmithKline Corporation Information
Table 76. GlaxoSmithKline Description and Major Businesses
Table 77. GlaxoSmithKline ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 78. GlaxoSmithKline Product
Table 79. GlaxoSmithKline Recent Development
Table 80. Helsinn Corporation Information
Table 81. Helsinn Description and Major Businesses
Table 82. Helsinn ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. Helsinn Product
Table 84. Helsinn Recent Development
Table 85. Heron Therapeutics Corporation Information
Table 86. Heron Therapeutics Description and Major Businesses
Table 87. Heron Therapeutics ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 88. Heron Therapeutics Product
Table 89. Heron Therapeutics Recent Development
Table 90. Merck Corporation Information
Table 91. Merck Description and Major Businesses
Table 92. Merck ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 93. Merck Product
Table 94. Merck Recent Development
Table 95. Tesaro Corporation Information
Table 96. Tesaro Description and Major Businesses
Table 97. Tesaro ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 98. Tesaro Product
Table 99. Tesaro Recent Development
Table 100. Global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Forecast by Regions (2021-2026) (K Pcs)
Table 101. Global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 102. Global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 103. Global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 104. North America: ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 105. North America: ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 106. Europe: ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 107. Europe: ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 108. Asia Pacific: ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Forecast by Region (2021-2026) (K Pcs)
Table 109. Asia Pacific: ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 110. Latin America: ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 111. Latin America: ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 112. Middle East and Africa: ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 113. Middle East and Africa: ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 114. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 115. Key Challenges
Table 116. Market Risks
Table 117. Main Points Interviewed from Key ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Players
Table 118. ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Customers List
Table 119. ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Distributors List
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Product Picture
Figure 2. Global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. 5-HT3 Inhibitors Product Picture
Figure 4. NK1 Inhibitors Product Picture
Figure 5. Other Product Picture
Figure 6. Global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Application in 2020 & 2026
Figure 7. Highly Emetogenic Chemotherapy
Figure 8. Moderately Emetogenic Chemotherapy
Figure 9. Low Emetogenic Chemotherapy
Figure 10. Other
Figure 11. ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Report Years Considered
Figure 12. Global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Market Size 2015-2026 (US$ Million)
Figure 13. Global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales 2015-2026 (K Pcs)
Figure 14. Global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Region (2015-2020)
Figure 16. Global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Region in 2019
Figure 17. Global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Market Share by Region (2015-2020)
Figure 18. Global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Market Share by Region in 2019
Figure 19. Global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue in 2019
Figure 21. ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Type (2015-2020)
Figure 23. Global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Type in 2019
Figure 24. Global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Market Share by Type (2015-2020)
Figure 25. Global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Market Share by Type in 2019
Figure 26. Global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Market Share by Price Range (2015-2020)
Figure 27. Global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Application (2015-2020)
Figure 28. Global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Application in 2019
Figure 29. Global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Market Share by Application (2015-2020)
Figure 30. Global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Market Share by Application in 2019
Figure 31. North America ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 32. North America ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Country in 2019
Figure 34. North America ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Market Share by Country in 2019
Figure 35. U.S. ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 36. U.S. ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 38. Canada ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Market Share by Type in 2019
Figure 40. North America ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Market Share by Application in 2019
Figure 41. Europe ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 42. Europe ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Country in 2019
Figure 44. Europe ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Market Share by Country in 2019
Figure 45. Germany ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 46. Germany ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. France ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. U.K. ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. Italy ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Russia ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Market Share by Type in 2019
Figure 56. Europe ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Market Share by Application in 2019
Figure 57. Asia Pacific ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 58. Asia Pacific ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Region in 2019
Figure 60. Asia Pacific ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Market Share by Region in 2019
Figure 61. China ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 62. China ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. Japan ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. South Korea ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. India ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. Australia ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Taiwan ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Indonesia ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Thailand ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Malaysia ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Philippines ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Vietnam ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Market Share by Type in 2019
Figure 84. Asia Pacific ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Market Share by Application in 2019
Figure 85. Latin America ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 86. Latin America ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Country in 2019
Figure 88. Latin America ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Market Share by Country in 2019
Figure 89. Mexico ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 90. Mexico ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Brazil ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Argentina ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Market Share by Type in 2019
Figure 96. Latin America ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Market Share by Application in 2019
Figure 97. Middle East and Africa ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 98. Middle East and Africa ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Country in 2019
Figure 100. Middle East and Africa ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Market Share by Country in 2019
Figure 101. Turkey ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 102. Turkey ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. Saudi Arabia ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. U.A.E ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Market Share by Type in 2019
Figure 108. Middle East and Africa ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Market Share by Application in 2019
Figure 109. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Helsinn Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Heron Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Tesaro Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. North America ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. North America ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Europe ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Europe ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Asia Pacific ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Asia Pacific ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Latin America ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 121. Latin America ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Middle East and Africa ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 123. Middle East and Africa ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Porter's Five Forces Analysis
Figure 125. Channels of Distribution
Figure 126. Distributors Profiles
Figure 127. Bottom-up and Top-down Approaches for This Report
Figure 128. Data Triangulation
Figure 129. Key Executives Interviewed
Similar Reports
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
- Publish Date: February 26, 2018
- $5370
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
- Publish Date: May 29, 2018
- $5370
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...
- Publish Date: May 1, 2016
- $5370
